Chemical Compound

(3S)-3-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-2-CARBAMOYL-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1,2-DICARBAMOYLETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}PENTYL]CARBAMOYL}PENTYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-CARBAMOYLPROPYL]CARBAMOYL}PENTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-CARBAMOYLETHYL]CARBAMOYL}-3-[(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-5-CARBAMIMIDAMIDO-2-[(2S)-5-CARBAMIMIDAMIDO-2-{[(2S)-1-[(2S)-2,6-DIAMINOHEXANOYL]PYRROLIDIN-2-YL]FORMAMIDO}PEN

CAS Registry Number 125093-93-8
返回搜索 申请报价
(3S)-3-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-2-CARBAMOYL-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1,2-DICARBAMOYLETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}PENTYL]CARBAMOYL}PENTYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-CARBAMOYLPROPYL]CARBAMOYL}PENTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-CARBAMOYLETHYL]CARBAMOYL}-3-[(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-5-CARBAMIMIDAMIDO-2-[(2S)-5-CARBAMIMIDAMIDO-2-{[(2S)-1-[(2S)-2,6-DIAMINOHEXANOYL]PYRROLIDIN-2-YL]FORMAMIDO}PEN 结构式
Primary record

(3S)-3-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-2-CARBAMOYL-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1,2-DICARBAMOYLETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}PENTYL]CARBAMOYL}PENTYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-CARBAMOYLPROPYL]CARBAMOYL}PENTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-CARBAMOYLETHYL]CARBAMOYL}-3-[(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-5-CARBAMIMIDAMIDO-2-[(2S)-5-CARBAMIMIDAMIDO-2-{[(2S)-1-[(2S)-2,6-DIAMINOHEXANOYL]PYRROLIDIN-2-YL]FORMAMIDO}PEN

库存
4,080 克
纯度
98.3 %
CAS
125093-93-8

化合物标识与属性

CAS
125093-93-8
PubChem CID
16144007
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCCN)N
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O

名称与同义词

  • VIP Antagonist
  • Viphyb
  • VIP neurotensin
  • VIPi
  • Neurotensin6-11VIP7-28
  • orb1943898
  • SCHEMBL29369173
  • DTXSID801365423
  • (Vip-neurotensin) hybrid antagonist
  • [Lys1,Pro2,5,Arg3,4,Tyr6]VIP
  • J413.961E
  • [Lys1, Pro2,5, Arg3,4, Tyr6]-VIP
  • 125093-93-8
  • [Lys1, Pro2,5, Arg3,4, Tyr6]-Vasoactive Intestinal Peptide human, porcine, rat
  • (3S)-3-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S)-5-AMINO-1-{[(1S)-5-AMINO-1-{[(1S)-1-{[(1S)-1-{[(1S)-2-CARBAMOYL-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1,2-DICARBAMOYLETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-METHYLBUTYL]CARBAMOYL}-2-HYDROXYETHYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}PENTYL]CARBAMOYL}PENTYL]CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}ETHYL]CARBAMOYL}-3-(METHYLSULFANYL)PROPYL]CARBAMOYL}-3-CARBAMOYLPROPYL]CARBAMOYL}PENTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-3-METHYLBUTYL]CARBAMOYL}-4-CARBAMIMIDAMIDOBUTYL]CARBAMOYL}-2-HYDROXYPROPYL]CARBAMOYL}-2-(4-HYDROXYPHENYL)ETHYL]CARBAMOYL}-2-CARBAMOYLETHYL]CARBAMOYL}-3-[(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-5-CARBAMIMIDAMIDO-2-[(2S)-5-CARBAMIMIDAMIDO-2-{[(2S)-1-[(2S)-2,6-DIAMINOHEXANOYL]PYRROLIDIN-2-YL]FORMAMIDO}PEN
  • H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2